JPMorgan Says These 12 Stocks Should Outperform On A Blue Wave In November

If Democrats sweep the election in November, these 12 stock could be big winners. 

In a tweet Monday, President Donald Trump warned that if voters wanted their 401k and stocks to “disintegrate and disappear,” they should cast their ballots for presumptive Democratic presidential nominee Joe Biden.

Biden’s lead in the polls over Trump has been widening over the past month, with the former vice president holding a roughly 10 point lead over the president according to RealClearPolitics’ average of eight major polls

“If the election were held today, we believe Vice President Joe Biden would win as part of a Democratic sweep,” said Sara Bianchi, head of U.S. public policy and political strategy research at Evercore ISI, in a note to clients as the coronavirus pandemic and recent social justice uprising reframe the election.

Trump isn’t alone in arguing that some of the former Vice President’s policy proposals would be potential negatives for stocks, with several analysts and investors saying the same. However, in a note out the week, JPMorgan strategists countered that a Biden win in November would actually be “neutral to a slight positive” for equities.

The strategists, led by Dubravko Lakos-Bujas, wrote that Biden would partially reverse the Republican corporate tax cut of 2017, increase the federal minimum wage, ease tariffs on China, and increase infrastructure spending, though they added that these policy priorities were set-out before the coronavirus and are likely to shift should the Democrat win the election.

“Given the current economic weakness, business recovery and job growth are likely to be prioritized over polices that could dampen economic growth and perhaps even jeopardize the desired 2022 midterm election outcome,” Lakos-Bujas wrote.

The JPMorgan strategists warned that a higher corporate tax rate would bring an earnings headwind of around $9 for S&P 500 earnings per share. However, a corporate tax hike would likely be lower than the 28% Biden has floated and would be offset by the softening of tariffs, infrastructure spending, and higher wages – all net positives for S&P 500 earnings.

And when it comes to a possible infrastructure bill, a Wolfe Research team led by Chris Senyek, said that a Democratic sweep could result in an infrastructure package of at least $1.5 trillion that would have an emphasis on clean energy and other environmentally-friendly initiatives.

Senyek also argues that Democrats would be much more positive on trade policy than the Trump administration has been. Given this, Senyek said U.S. companies paying heavy tariffs and U.S. exporters with significant exposure to China would be big winners.

“Further, a more diplomatic approach to domestic/foreign policy will likely result in lower volatility and risk premia,” the JPMorgan strategists added. 

Should Democrats sweep the election in November, JPMorgan selected a basket of stocks that should outperform under a Democratic agenda. Names in the basket include electric vehicle makers Tesla (NASDAQ: TSLA) and Nikola (NASDAQ: NKLA), healthcare stocks Johnson & Johnson (NYSE: JNJ) and CVS (NYSE: CVS), and names including Procter & Gamble (NYSE: PG), Boeing (NYSE: BA), DuPont (NYSE: DD), and Nike (NYSE: NKE) that will benefit from a tariff de-escalation. 

Lakos-Bujas added that a higher minimum wage would have a positive impact on consumer spending, and would be a positive for companies despite higher costs and some employment losses. 

“Distinguishing winners and losers will depend on businesses who will see incremental demand due to rising disposable income, lower labor intensity (revenue/employees) and higher margins,” the strategists wrote.

As a result, names like Apple (NASDAQ: AAPL), Facebook (NASDAQ: FB), Google-parent Alphabet (NASDAQ: GOOGL, GOOG), Twitter (NYSE: TWTR), and Visa (NYSE: V) would also be outperformers. 

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More